News2026-10-23 10:54 UTC

Moderna and Merck Report 42% Reduction in Melanoma Deaths with mRNA Vaccine

Clinical data show the personalized mRNA cancer vaccine from Moderna and Merck cuts death and recurrence rates by 42% in melanoma patients, prompting regulatory engagement. …

More News

10-23 10:54 UTCOpenAI Fires Three Safety Researchers Over Signal Chats
10-23 10:54 UTCAmazon Announces Alexa Tablet as Low‑Cost iPad Rival
10-23 10:54 UTCSpaceX Negotiates Access to 80,000 Cell Sites for New Network
10-23 10:55 UTCPolling Firm Fabrication Raises Questions for Kalshi Contracts
10-23 10:55 UTCBitcoin Steadies Near $81,700 as Altcoins Rebound